Biotech

All Articles

Ionis axes eye disease from aim ats of Roche-partnered possibility after data let down

.Yet Another of Ionis Pharmaceuticals' vital midphase readouts has fallen short of expectations, mot...

Biogen's CEO pointed out no high-risk deals in 2023. He prepares to be daring

.While Biogen's pharma peers are actually hunting for late-stage assets along with little risk, chie...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has been actually a biotech trying to find a pipe after it junked its own lead res...

Biogen walks away from Denali Alzheimer's collab

.Biogen has actually restored liberties to an early Alzheimer's condition system to Denali Therapeut...

Takeda faucets new mind people oncology organization-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings an...

Vertex, beaten by AATD once again, falls 2 properties on throw away heap

.Tip's attempt to handle a rare hereditary illness has actually attacked one more problem. The biote...

Vir gains 3 T-cell engagers from Sanofi, gives up 25% of team

.Vir Medical's second-quarter incomes report wasn't except large information. The company invited a ...

Galapagos stops briefly CAR-T tissue treatment trial over Parkinsonism scenario

.Galapagos has paused application in a test of a BCMA-directed CAR-T cell treatment, pumping the bra...

James Wilson leaving behind Penn to launch pair of brand new biotechs

.After greater than thirty years, genetics therapy trailblazer James Wilson M.D., Ph.D., is actually...

3 biotechs try to beat the summer season heat by losing workers

.As biotechs attempt to transform a fresh web page in August, at least three providers have dropped ...